Iran to launch 4 stem cell research centers abroad
In line with transferring technology and technical knowhow, Islamic Republic of Iran intends to set up a number of four equipped research centers in Iraq, Oman, Azerbaijan Republic and Syria.
Scientists generate an atlas of the human genome using stem cells
Scientists from the Hebrew University of Jerusalem have generated an atlas of the human genome using a state-of-the-art gene editing technology and human embryonic stem cells, illuminating the roles that our genes play in health and disease. The scientists have reported their findings in the journal Nature Cell Biology.
CRISPR/Cas9 silences gene associated with high cholesterol
Biomedical engineers at Duke University have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene repression lasting for six months after a single treatment.
Scientists build synthetic embryos
Dutch scientists have built "synthetic" embryos in their laboratory using mouse cells other than sperm and eggs.
FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma
The Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR-T cell therapy – for the treatment of adult patients who have relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have relapsed or are ineligible for an autologous stem cell transplant (ASCT).
Test implementation standards in the section of laboratory services will be presented to users
The manager of strategic technologies laboratory network stated: in the laboratory services section, test implementation standards and search of tests related to products will be presented to users.
New Company, MAGiQ, Aims to Develop Stem Cell Therapies for ALS and Like Diseases
A new Japanese joint venture company called MAGiQ Therapeutics — the result of a collaboration between Q Therapeutics and Reprocell — aims to develop cell and gene therapies for demyelinating and degenerative diseases of the central nervous system.
NHS preparing to offer ‘game-changing’ cancer treatment
NHS preparing to offer ‘game-changing’ cancer treatment
Pediatric brainstem cancer eradicated in mice using CAR-T treatment
Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated.
GE launching its viral vector factory-in-a-box prefab KUBio labs
GE, best known for making lightbulbs and jet engines, is launching its KUBio factory-in-a-box prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines, oncolytic viruses, and gene and cell therapies.
